ReviewAdvanced drug delivery reviews2021

Challenges and opportunities for antiviral monoclonal antibodies as COVID-19 therapy.

Carlos Cruz-Teran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.